The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease-Reference-Cited by-同舟云学术

The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease

Published:2017-01-07 Issue:1 Volume:17 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Young Jim,Weis Nina,Hofer Harald,Irving William,Weiland Ola,Giostra Emiliano,Pascasio Juan Manuel,Castells Lluis,Prieto Martin,Postema Roelien,Lefevre Cinira,Evans David,Bucher Heiner C.,Calleja Jose Luis

Funder

Bristol-Myers Squibb

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-016-2106-x.pdf

Reference31 articles.

1. Webster DP, Klenerman P, Dusheiko GM. Hepatitis C. Lancet. 2015;385:1124–35.

2. Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, et al. The present and future disease burden of hepatitis C virus (HCV) infection with today’s treatment paradigm. J Viral Hepat. 2014;21 Suppl 1:34–59.

3. Razavi H, Elkhoury AC, Elbasha E, Estes C, Pasini K, Poynard T, et al. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology. 2013;57:2164–70.

4. EASL. Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2011;55:245–64.

5. Antaki N, Craxi A, Kamal S, Moucari R, Van der MS, Haffar S, et al. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report. Liver Int. 2010;30:342–55.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global dynamics of an HCV model with full logistic terms and the host immune system;Advances in Epidemiological Modeling and Control of Viruses;2023

2. Efficacy and Safety of Sofosbuvir-based Regimens in Hepatitis C Patients With Decompensated Cirrhosis: A Systematic Review and Meta-analysis;Journal of Clinical and Translational Hepatology;2022-06-28

3. Concurrent Determination of Daclatasvir and Sofosbuvir in Pure Binary Mixture and Their Combined Film Coated Tablets by a Simple Stability Indicating RP-HPLC Method;Research Journal of Pharmacy and Technology;2021-11-30

4. Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study;BMC Gastroenterology;2020-03-05

5. A dynamic model and some strategies on how to prevent and control hepatitis c in mainland China;BMC Infectious Diseases;2019-08-16